Guiheen Lawrence P. — SEC Form 4 filings
SEC reporting owner CIK 1554353. 7 Form 4 filings on record with FilingPulse; latest filed 2026-03-17.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2024-02-28 to 2026-03-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 4 legs across 3 filings — 38,000 shares, $768,024 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 16.
- Largest priced transaction: sale of 20,000 shares @ $20.96 ($419,200) in ADMA BIOLOGICS, INC., filed 2025-06-11.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| ADMA BIOLOGICS, INC. (ADMA) | Director | 7 | — | 4 legs · 38,000 sh · $768,024 | 16 |
Form 4 filings — Guiheen Lawrence P.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-03-17 | 4 | ADMA BIOLOGICS, INC. (ADMA) | Option exercise (M): 30,000 @ $3.66 · Gift (G): 30,000 @ $0 · Gift (G): 30,000 @ $0 · Option exercise (M): 30,000 (derivative) @ $0 | EDGAR |
| 2026-02-11 | 4 | ADMA BIOLOGICS, INC. (ADMA) | Grant/award (A): 10,690 @ $0 · Grant/award (A): 17,730 (derivative) @ $0 | EDGAR |
| 2025-06-11 | 4 | ADMA BIOLOGICS, INC. (ADMA) | Sale (S): 20,000 @ $20.96 | EDGAR |
| 2025-05-23 | 4 | ADMA BIOLOGICS, INC. (ADMA) | Option exercise (M): 7,779 @ $5.96 · Sale (S): 7,779 @ $20.32 · Option exercise (M): 1,221 @ $5.96 · Sale (S): 1,221 @ $20.12 · Option exercise (M): 7,779 (derivative) @ $0 · Option exercise (M): 1,221 (derivative) @ $0 | EDGAR |
| 2025-02-21 | 4 | ADMA BIOLOGICS, INC. (ADMA) | Grant/award (A): 10,889 @ $0 · Grant/award (A): 16,279 (derivative) @ $0 | EDGAR |
| 2024-09-11 | 4 | ADMA BIOLOGICS, INC. (ADMA) | Option exercise (M): 9,000 @ $10.80 · Sale (S): 9,000 @ $18.47 · Option exercise (M): 9,000 (derivative) @ $10.80 | EDGAR |
| 2024-02-28 | 4 | ADMA BIOLOGICS, INC. (ADMA) | Grant/award (A): 24,040 @ $0 · Grant/award (A): 37,541 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1554353 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →